AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
62.72
+0.35 (0.57%)
At close: Mar 23, 2026, 4:00 PM EDT
63.66
+0.94 (1.50%)
After-hours: Mar 23, 2026, 6:57 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 10 analysts that cover AnaptysBio stock have a consensus rating of "Strong Buy" and an average price target of $72.6, which forecasts a 15.75% increase in the stock price over the next year. The lowest target is $20 and the highest is $100.
Price Target: $72.6 (+15.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 6 | 6 | 6 | 6 | 6 | 4 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 12 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $70 → $90 | Strong Buy | Maintains | $70 → $90 | +43.49% | Mar 17, 2026 |
| Wedbush | Wedbush | Buy Maintains $60 → $75 | Buy | Maintains | $60 → $75 | +19.58% | Mar 12, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $36 → $50 | Hold | Maintains | $36 → $50 | -20.28% | Mar 9, 2026 |
| Stifel | Stifel | Strong Buy Maintains $56 → $85 | Strong Buy | Maintains | $56 → $85 | +35.52% | Mar 5, 2026 |
| Barclays | Barclays | Buy Maintains $78 → $79 | Buy | Maintains | $78 → $79 | +25.96% | Mar 4, 2026 |
Financial Forecast
Revenue This Year
139.32M
from 234.60M
Decreased by -40.61%
Revenue Next Year
185.98M
from 139.32M
Increased by 33.49%
EPS This Year
-4.67
from -0.46
EPS Next Year
-5.50
from -4.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 158.6M | 247.8M | |||
| Avg | 139.3M | 186.0M | |||
| Low | 87.3M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -32.4% | 77.9% | |||
| Avg | -40.6% | 33.5% | |||
| Low | -62.8% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.37 | -1.74 | |||
| Avg | -4.67 | -5.50 | |||
| Low | -7.67 | -9.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.